Related references
Note: Only part of the references are listed.Update of contemporary antimicrobial resistance rates across China: reference testing results for 12 medical centers (2011)
Ronald N. Jones et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2013)
Antimicrobial activity of daptomycin tested against Gram-positive pathogens collected in Europe, Latin America, and selected countries in the Asia-Pacific Region (2011)
Helio S. Sader et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2013)
Safety and Efficacy of Daptomycin as First-Line Treatment for Complicated Skin and Soft Tissue Infections in Elderly Patients: An Open-Label, Multicentre, Randomized Phase IIIb Trial
Alexander Konychev et al.
DRUGS & AGING (2013)
Linezolid versus vancomycin for meticillin-resistant Staphylococcus aureus infection: a meta-analysis of randomised controlled trials
Mao Mao An et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Efficacy and safety of intravenous daptomycin in Japanese patients with skin and soft tissue infections
Naoki Aikawa et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2013)
Randomized Controlled Trial of the Safety and Efficacy of Daptomycin versus Standard-of-Care Therapy for Management of Patients with Osteomyelitis Associated with Prosthetic Devices Undergoing Two-Stage Revision Arthroplasty
Ivor Byren et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Comparative randomised clinical trial against glycopeptides supports the use of daptomycin as first-line treatment of complicated skin and soft-tissue infections
S. R. Quist et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance
Ian M. Gould et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Pharmacokinetics and Tolerability of Single-Dose Daptomycin in Young Infants
Michael Cohen-Wolkowiez et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Cost-Effectiveness Analysis of Linezolid, Daptomycin, and Vancomycin in Methicillin-Resistant Staphylococcus aureus: Complicated Skin and Skin Structure Infection Using Bayesian Methods for Evidence Synthesis
Mark Bounthavong et al.
VALUE IN HEALTH (2011)
Daptomycin Versus Other Antimicrobial Agents for the Treatment of Skin and Soft Tissue Infections: A Meta-Analysis
Ioannis A. Bliziotis et al.
ANNALS OF PHARMACOTHERAPY (2010)
Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis-a pharmacokinetic study
Jan T. Kielstein et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
Leonard A. Mermel et al.
CLINICAL INFECTIOUS DISEASES (2009)
The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas
P. E. Pertel et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections
Adam L. Hersh et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Vancomycin-resistant staphylococcus aureus in the United States, 2002-2006
Dawn M. Sievert et al.
CLINICAL INFECTIOUS DISEASES (2008)
A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria
D. E. Katz et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Daptomycin therapy for invasive Gram-positive bacterial infections in children
Monica I. Ardura et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Daptomycin versus vancomycin for complicated skin and skin structure infections: Clinical and economic outcomes
Susan L. Davis et al.
PHARMACOTHERAPY (2007)
Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004)
Gary J. Moet et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Methicillin-resistant S-aureus infections among patients in the emergency department
Gregory J. Moran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Practice guidelines for the diagnosis and management of skin and soft-tissue infections
DL Stevens et al.
CLINICAL INFECTIOUS DISEASES (2005)
Newer treatment options for skin and soft tissue infections
M Raghavan et al.
DRUGS (2004)
The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections
RD Arbeit et al.
CLINICAL INFECTIOUS DISEASES (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
A practical guide to the treatment of complicated skin and soft tissue infections
HB Fung et al.
DRUGS (2003)
Once-daily dosing in dogs optimizes daptomycin safety
FB Oleson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Development of daptomycin for Gram-positive infections
FP Tally et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains
MJ Rybak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
